RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 120 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $86,000 | -32.8% | 31,418 | -18.5% | 0.03% | -19.0% |
Q1 2017 | $128,000 | -43.4% | 38,559 | -59.4% | 0.04% | -30.0% |
Q4 2016 | $226,000 | -56.3% | 94,869 | -59.1% | 0.06% | -36.8% |
Q2 2016 | $517,000 | -71.3% | 231,756 | -73.2% | 0.10% | -63.3% |
Q1 2016 | $1,800,000 | -52.5% | 865,197 | -30.9% | 0.26% | -36.5% |
Q4 2015 | $3,791,000 | +0.3% | 1,251,289 | -18.2% | 0.41% | +12.1% |
Q3 2015 | $3,778,000 | -32.6% | 1,529,481 | -12.5% | 0.36% | -33.6% |
Q2 2015 | $5,609,000 | +377.4% | 1,747,400 | +430.9% | 0.55% | +376.5% |
Q1 2015 | $1,175,000 | +152.1% | 329,146 | +60.4% | 0.12% | +161.4% |
Q4 2014 | $466,000 | -75.2% | 205,169 | -78.8% | 0.04% | -73.0% |
Q3 2014 | $1,879,000 | -30.0% | 968,599 | +31.0% | 0.16% | -22.7% |
Q2 2014 | $2,684,000 | +89.3% | 739,492 | +102.3% | 0.21% | +124.5% |
Q1 2014 | $1,418,000 | +3.1% | 365,562 | -24.2% | 0.09% | +44.6% |
Q4 2013 | $1,375,000 | -34.0% | 482,557 | -17.0% | 0.06% | -31.6% |
Q3 2013 | $2,082,000 | +31.6% | 581,485 | +22.7% | 0.10% | +41.8% |
Q2 2013 | $1,582,000 | – | 473,737 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |